Australia - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 16 Issue 2

Navigating the TGA’s Requirements for Combination Products

Combination products are integral to the healthcare system and play an increasingly important role in patient safety and medicinal usability, enhancing therapeutic b...

8 July 2024 Volume 16 Issue 2 | Editorial Archive Australia | healthcare

Continue Reading →

News

Mayne pharma launches generic version of Monodox in Australia

The drug is indicated for the treatment of a number of infections, including adjunctive therapy in severe acne Australia's Mayne Pharma Group recently annou...